21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
10.86.Z - Production of homogenized food products and diet food
10.89.Z - Production of other food products, not elsewhere classified
20.42.Z - Manufacture of cosmetics and toilet preparations
21.10.Z - Manufacture of basic pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
2020 | 2021 | 2022 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets | 370 | 369 | 234 | -36,6 |
Gross profit (loss) | -8,2 | -9,3 | 1,4 | 115,2 |
Net profit (loss) | -9,4 | -11,2 | 1,4 | 112,6 |
Liabilities and provisions for liabilities | 378 | 388,2 | 251,7 | -35,2 |
Income tax | 1,2 | 2 | 0 | -100 |
Working assets | 199,5 | 359,8 | 224,8 | -37,5 |
Equity capital | -7,9 | -19,2 | -17,8 | 7,4 |
Basic operational activity income | 115,2 | 153,7 | 91,1 | -40,7 |
% | % | % | p.p. | |
Profitability of capital | -4,8 | |||
Equity capital to total assets | -2,1 | -5,2 | -7,6 | -2,4 |
Gross profit margin | -7,1 | -6 | 1,5 | 7,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane